Targeted therapies are drugs that find and attack cancer cells. There are many different types of targeted therapy.
Targeted therapies are drugs that find and attack cancer cells. There are many different types of targeted therapy. Each one targets something in or around the cancer cell that is helping it grow and survive.
You can read more about the most common types below.
If you know the name of the drug you are looking for, you can use our list of targeted and immunotherapy drugs to find it. This gives more information about:
- what each treatment is
- how you have it
- possible side effects.
Tumours need a blood supply to survive. Without a good blood supply, the tumour does not get the oxygen and nutrients it needs. This may slow the tumour’s growth, or sometimes cause it to shrink.
Angiogenesis inhibitors block the chemical signals that cells use to make blood vessels grow. This makes it difficult for a tumour to develop the network of blood vessels it needs to get a blood supply.
All cells have receptors on their surface. Receptors help cells send or receive signals. A receptor is a bit like a lock. Only the right key fits the lock. Another cell or substance can only connect to the receptor if it is the right fit.
Monoclonal antibodies are made so they can only connect to one type of receptor. Most monoclonal antibodies target receptors that are mainly found on cancer cells. Some target receptors that are found on other cells in the body.
By connecting to the cell’s receptor, a monoclonal antibody could:
- block signals that tell cancer cells to grow and divide (also called a cancer growth inhibitor)
- block signals that help cancer cells develop a blood supply (also called an angiogenesis inhibitor)
- block signals that stop white blood cells attacking cancer cells (also called a checkpoint inhibitor)
- help the immune system recognise cancer cells (also called an immunotherapy)
- block signals to protect the bones from damage causes by some types of cancer or cancer treatments – for example, denosumab (Xgeva®, Prolia®)
- carry a chemotherapy drug straight to the cancer cell.
A monoclonal antibody may also carry radiation directly to the cancer cell. This treatment is not widely used and may only be available as part of a research trial (clinical trial).
PARPs are proteins that help damaged cells repair themselves.
PARP inhibitors block (inhibit) how PARP proteins work. This means cancer cells may become more damaged and die.
Some cancer cells have a genetic change called homologous recombination deficiency (HRD). PARP inhibitor drugs are even more effective against cells with HRD.
Before you have targeted therapy, you might have tests to find out if the treatment is likely to work for you.
The tests may check whether the cancer cells have a certain type of receptor for a monoclonal antibody to target.
You may have tests to look for genetic changes in your cancer cells. These include testing for HRD before PARP inhibitor treatment.
Doctors may check the cancer cells using a blood test, or by taking a sample of tissue (a biopsy). If you have had an operation, they may already have a sample of your tissue they can test. This kind of testing is not needed for all targeted therapies. If you need these tests, your doctor or nurse can tell you more.
Targeted therapies work differently to other cancer treatments such as chemotherapy. Different chemotherapy drugs often have similar side effects because they work in the same way.
The side effects of targeted therapy can be more varied. This is because the different types of drugs target cancer cells in different ways.
Some targeted therapy drugs can have more than one action. For example, a cancer growth inhibitor may also be an angiogenesis inhibitor.
Your specialist doctor, nurse and pharmacist will talk to you about the side effects of treatment.
How we can help
Chat online anonymously to others who understand what you are going through. Our community is available 24/7 and has dedicated forums where you can get advice and ask our experts.